Topic: Vaccine - CIAO Search Results

Author:: Joelle M. Abi-Rached and Pascale Salameh
Publication Date:: 01-2021
Content Type:: Working Paper
Institution:: Arab Reform Initiative (ARI)
Abstract:: As countries begin to roll out vaccination for COVID-19, the Lebanese caretaker government has yet to provide details about its vaccination strategy, raising concerns about its ability to provide vaccines due to the country’s economic and governance crisis. This paper, written by public health professionals, raises a number of questions about the vaccination strategy that the government should address and calls for an open, inclusive, and transparent process to placate the worries of citizens given the privatization and politicization of the country’s health sector.
Topic:: Public Health, Vaccine, Pandemic, and COVID-19
Political Geography:: Middle East and Lebanon

Author:: Reinhilde Veugelers and Georg Zachmann
Publication Date:: 04-2020
Content Type:: Policy Brief
Institution:: Bruegel
Abstract:: This Policy Contribution proposes a staged support scheme to tackle the COVID-19 vaccine challenge and a moon shot programme to meet the challenge of future pandemics.
Topic:: Health, Science and Technology, Innovation, Vaccine, and COVID-19
Political Geography:: Europe

Author:: Roxanne Oroxom and Amanda Glassman
Publication Date:: 06-2019
Content Type:: Working Paper
Institution:: Center for Global Development
Abstract:: With a vision of “creating equal access to new and underused vaccines,” Gavi set several coverage-specific targets for 2020 as part of its Phase IV strategy, including the immunization of an additional 300 million children, increased pentavalent 3 and measles-containing vaccine (MCV) 1 coverage, and greater equity in coverage across wealth quintiles.[1] The strategy also called for broadening protection through improved routine coverage and the introduction of new vaccines.[2]
Topic:: Health, Children, Public Health, and Vaccine
Political Geography:: Global Focus

Author:: Amanda Glassman, Cordelia Kenney, and Janeen Madan Keller
Publication Date:: 06-2019
Content Type:: Working Paper
Institution:: Center for Global Development
Abstract:: Child vaccination remains among the most cost-effective uses of public and aid monies.[1] In a highly contested funding environment where priorities must be set for the allocation of scarce concessional resources, investment in expanding the availability and coverage of cost-effective vaccination must come at the top of the list. Gavi’s mission—saving children’s lives and protecting people’s health by increasing equitable use of vaccines—remains highly relevant. Gavi and its partners have made enormous progress towards increasing equity in the introduction of vaccines; children living in the lowest-income countries now have access to the same set of vaccines as those living in high-income countries. Gavi and partners have also contributed to increased coverage; immunization rates are higher in Burundi and Rwanda, for example, than in many places in the United States and Europe. Yet the effects of under-immunization anywhere can have global implications everywhere, as recent outbreaks illustrate. New or dormant threats are also a new reality—newly vaccine-preventable diseases like Ebola or virulent flu strains can spread swiftly and lethally in an interconnected world.
Topic:: Health, Public Health, Vaccine, and Immunization
Political Geography:: Global Focus

Author:: Aspen Institute
Publication Date:: 07-2019
Content Type:: Working Paper
Institution:: Aspen Institute
Abstract:: The Sabin-Aspen Vaccine Science & Policy Group convened in 2018 to explore challenges and opportunities to develop a universal influenza vaccine. The group’s recommendations on how to overcome the scientific, financial and organizational barriers to developing a vaccine are synthesized in this report published in July 2019.
Topic:: Vaccine, Pandemic, Medicine, and Influenza
Political Geography:: Global Focus

Refine your search